These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6969479)

  • 1. Immunological considerations in connective tissue diseases.
    Littman BH
    Triangle; 1980; 19(2):53-60. PubMed ID: 6969479
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinico-immunological analysis of clinical variants of connective tissue dysplasia].
    Iakovlev VM; Glotov AV; Nechaeva GI; Konenkov VI
    Ter Arkh; 1994; 66(5):9-13. PubMed ID: 7940354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production.
    Greidinger EL; Gazitt T; Jaimes KF; Hoffman RW
    Arthritis Rheum; 2004 Jul; 50(7):2216-22. PubMed ID: 15248220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The association of complement with common connective tissue diseases - a review].
    Arason GJ
    Laeknabladid; 2008 May; 94(5):371-4. PubMed ID: 18460733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is anti-U1-RNP autoantibody positive connective tissue disease genetically distinct?
    Hoffman RW; Sharp GC
    J Rheumatol; 1995 Apr; 22(4):586-9. PubMed ID: 7791147
    [No Abstract]   [Full Text] [Related]  

  • 6. T cell receptor beta-chain third complementarity-determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease.
    Talken BL; Holyst MM; Lee DR; Hoffman RW
    Arthritis Rheum; 1999 Apr; 42(4):703-9. PubMed ID: 10211884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases.
    Decker P; Briand JP; de Murcia G; Pero RW; Isenberg DA; Muller S
    Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological phenomena in endogenous psychoses].
    Firko M; Kiejna A; Leszek J
    Psychiatr Pol; 1979; 13(3):303-7. PubMed ID: 314116
    [No Abstract]   [Full Text] [Related]  

  • 9. [Autoantibodies in connective tissue diseases].
    Mimori T
    Nihon Rinsho; 2005 May; 63 Suppl 5():187-92. PubMed ID: 15954347
    [No Abstract]   [Full Text] [Related]  

  • 10. [What's the significance of the HLA system in dermatology?].
    Koeppel MC; Sayag J
    Ann Dermatol Venereol; 1988; 115(1):99-112. PubMed ID: 2967044
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress in study of autoantibodies in connective tissue diseases].
    Mimori T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):23-7. PubMed ID: 11963176
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological features of diffuse connective tissue diseases.
    Burgio GR; Martini A
    Eur J Pediatr; 1990 Jan; 149(4):224-31. PubMed ID: 2406145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to immunology.
    Barber HR
    Prog Clin Biol Res; 1981; 70():3-16. PubMed ID: 6975946
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological investigation in children with juvenile chronic arthritis.
    Sedivá A; Hoza J; Nĕmcová D; Pospísilová D; Bartůnková J; Vencovský J
    Med Sci Monit; 2001; 7(1):99-104. PubMed ID: 11208502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological analysis of pulmonary hypertension in connective tissue diseases.
    Nishimaki T; Aotsuka S; Kondo H; Yamamoto K; Takasaki Y; Sumiya M; Yokohari R
    J Rheumatol; 1999 Nov; 26(11):2357-62. PubMed ID: 10555891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineutrophil cytoplasmic autoantibodies (ANCA)--in patients with connective tissue diseases].
    Prus V; Sram K; Fustar V
    Reumatizam; 1994; 41(2):9-11. PubMed ID: 8693198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunology of systemic connective tissue diseases].
    Hána I; Dostál C; Bardfeld R
    Cas Lek Cesk; 1984 Sep; 123(38-39):1178-81. PubMed ID: 6498919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endothelial antigenicity in diffuse connective tissue diseases].
    de Mendonça LL; Yoshinari NH; Balthazar PA; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):293-7. PubMed ID: 8029603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connective tissue diseases: advances in diagnosis and management.
    Vyse TJ; Walport MJ
    Br J Hosp Med; 1993 Jul 14-Aug 17; 50(2-3):121-32. PubMed ID: 8353664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.